ReviewCurrent hematologic malignancy reports2019

Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice.

Richard E ClarkPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.